Comparison of the Major Clinical Outcomes for the Use of Endeavor® and Resolute Integrity® Zotarolimus-Eluting Stents During a Three-Year Follow-up

BACKGROUND: Endeavor®-zotarolimus-eluting stent (E-ZES) was the first ZES to be developed, and Resolute integrity®-ZES (I-ZES) has been developed more recently. Comparative studies on long-term usage of these two ZESs have been rare. OBJECTIVES: The aim of this study was to compare the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong Hoon, Her, Ae-Young, Rha, Seung-Woon, Choi, Byoung Geol, Choi, Se Yeon, Byun, Jae Kyeong, Park, Yoonjee, Kang, Dong Oh, Jang, Won Young, Kim, Woohyeun, Choi, Cheol Ung, Park, Chang Gyu, Seo, Hong Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218769/
https://www.ncbi.nlm.nih.gov/pubmed/32489777
http://dx.doi.org/10.5334/gh.374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218769/
https://www.ncbi.nlm.nih.gov/pubmed/32489777
http://dx.doi.org/10.5334/gh.374

Ejemplares similares